Author
Listed:
- Ryou-u Takahashi
(National Cancer Center Research Institute)
- Hiroaki Miyazaki
(National Cancer Center Research Institute)
- Fumitaka Takeshita
(National Cancer Center Research Institute)
- Yusuke Yamamoto
(National Cancer Center Research Institute)
- Kaho Minoura
(Genomic Application Group, Japan Diagnostics and Genomics, Agilent Technologies Japan Ltd., 9-1)
- Makiko Ono
(National Cancer Center Research Institute)
- Makoto Kodaira
(National Cancer Center Hospital, 1-1)
- Kenji Tamura
(National Cancer Center Hospital, 1-1)
- Masaki Mori
(Graduated School of Medicine, Osaka University)
- Takahiro Ochiya
(National Cancer Center Research Institute)
Abstract
Cancer stem cells (CSCs) have been identified in various types of cancer; however, the mechanisms by which cells acquire CSC properties such as drug resistance and tumour seeding ability are not fully understood. Here, we identified microRNA-27b (miR-27b) as a key regulator for the generation of a side-population in breast cancer cells that showed CSC properties, and also found that the anti-type II diabetes (T2D) drug metformin reduced this side-population via miR-27b-mediated repression of ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (ENPP1), which is involved in T2D development. ENPP1 induced the generation of the side-population via upregulation of the ABCG2 transporter. ENPP1 was also identified as a substrate of the 26S proteasome, the activity of which is downregulated in CSCs. Overall, these results demonstrate that a T2D-associated gene plays an important role in tumour development and that its expression is strictly controlled at the mRNA and protein levels.
Suggested Citation
Ryou-u Takahashi & Hiroaki Miyazaki & Fumitaka Takeshita & Yusuke Yamamoto & Kaho Minoura & Makiko Ono & Makoto Kodaira & Kenji Tamura & Masaki Mori & Takahiro Ochiya, 2015.
"Loss of microRNA-27b contributes to breast cancer stem cell generation by activating ENPP1,"
Nature Communications, Nature, vol. 6(1), pages 1-15, November.
Handle:
RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms8318
DOI: 10.1038/ncomms8318
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms8318. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.